CHIORAZZI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 20.652
AS - Asia 14.775
EU - Europa 9.943
SA - Sud America 1.745
AF - Africa 296
OC - Oceania 76
Continente sconosciuto - Info sul continente non disponibili 28
Totale 47.515
Nazione #
US - Stati Uniti d'America 19.475
SG - Singapore 5.058
CN - Cina 2.963
VN - Vietnam 2.962
IT - Italia 2.203
HK - Hong Kong 1.588
DE - Germania 1.553
RU - Federazione Russa 1.443
BR - Brasile 1.301
SE - Svezia 1.044
CA - Canada 1.004
IE - Irlanda 816
GB - Regno Unito 584
UA - Ucraina 573
FR - Francia 545
IN - India 432
KR - Corea 282
FI - Finlandia 252
BD - Bangladesh 220
ID - Indonesia 215
AT - Austria 189
JP - Giappone 167
AR - Argentina 166
TR - Turchia 161
NL - Olanda 129
IQ - Iraq 128
DK - Danimarca 121
ES - Italia 105
ZA - Sudafrica 99
MX - Messico 92
PK - Pakistan 88
PL - Polonia 85
LT - Lituania 75
SA - Arabia Saudita 68
CH - Svizzera 66
PH - Filippine 62
EC - Ecuador 61
AU - Australia 55
CO - Colombia 55
BE - Belgio 54
MY - Malesia 51
VE - Venezuela 50
IR - Iran 42
AE - Emirati Arabi Uniti 34
CL - Cile 32
EG - Egitto 32
PY - Paraguay 32
UZ - Uzbekistan 32
MA - Marocco 31
TN - Tunisia 28
ET - Etiopia 25
JO - Giordania 25
KE - Kenya 25
EU - Europa 23
TW - Taiwan 22
KZ - Kazakistan 21
NZ - Nuova Zelanda 20
OM - Oman 20
NP - Nepal 19
AZ - Azerbaigian 18
PE - Perù 18
TH - Thailandia 17
CZ - Repubblica Ceca 15
UY - Uruguay 15
BO - Bolivia 14
CR - Costa Rica 14
IL - Israele 14
DZ - Algeria 13
HN - Honduras 13
AL - Albania 12
HU - Ungheria 12
PS - Palestinian Territory 11
RO - Romania 11
JM - Giamaica 10
NG - Nigeria 10
BG - Bulgaria 9
NI - Nicaragua 9
PA - Panama 9
KG - Kirghizistan 8
BH - Bahrain 7
DO - Repubblica Dominicana 7
HR - Croazia 7
SN - Senegal 7
AO - Angola 6
MD - Moldavia 6
RS - Serbia 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
GR - Grecia 5
KW - Kuwait 5
LB - Libano 5
LV - Lettonia 5
NO - Norvegia 5
CI - Costa d'Avorio 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
BN - Brunei Darussalam 3
GE - Georgia 3
GT - Guatemala 3
KH - Cambogia 3
Totale 47.462
Città #
Singapore 3.146
Ann Arbor 2.860
Ashburn 1.710
Dallas 1.567
Hong Kong 1.509
San Jose 1.290
Ho Chi Minh City 870
Frankfurt am Main 813
Dublin 790
Woodbridge 773
Milan 761
Chandler 745
Toronto 702
Hanoi 684
Wilmington 640
Houston 612
Fairfield 566
New York 552
Dearborn 547
Jacksonville 546
Los Angeles 455
Beijing 433
Santa Clara 400
Chicago 312
Princeton 302
Council Bluffs 300
Boardman 296
Seattle 256
Hefei 252
The Dalles 251
Seoul 242
Nanjing 237
Shanghai 176
Lauterbourg 167
Buffalo 165
Vienna 163
Cambridge 162
Jakarta 149
São Paulo 119
Guangzhou 110
Moscow 110
Orem 105
Helsinki 99
Da Nang 96
Dong Ket 92
Munich 92
Tokyo 92
Haiphong 90
Lachine 85
Lawrence 78
Altamura 73
Chennai 73
Nanchang 73
Shenyang 73
Rome 72
Montreal 68
London 65
Hải Dương 62
Warsaw 59
Denver 58
Vilnius 58
Ha Long 57
Phoenix 57
Baghdad 55
Rio de Janeiro 52
Andover 51
Brooklyn 51
Biên Hòa 50
Pune 50
Amsterdam 49
Atlanta 49
Carate Brianza 49
Zurich 49
Changsha 48
Stockholm 48
Hangzhou 47
Nuremberg 46
Jinan 45
Can Tho 43
Falls Church 43
Johannesburg 43
Zhengzhou 43
San Francisco 42
Ottawa 41
San Diego 41
Basingstoke 40
Ninh Bình 40
Quận Bình Thạnh 40
Fremont 39
Bắc Ninh 38
Jiaxing 38
Poplar 38
Brussels 37
Tianjin 37
Turku 36
Kunming 35
Columbus 34
Manchester 34
Istanbul 32
Florence 31
Totale 30.001
Nome #
CIPN and its mechanism of development 624
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 578
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 509
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 497
Studio della neurotossicità periferica indotta da farmaci antitubulinici in modelli sperimentali in vitro e in vivo 494
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 454
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 446
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 432
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 429
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 426
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 423
Age-related changes in the function and structure of the peripheral sensory pathway in mice 422
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 420
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 416
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 413
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 406
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 399
Artificial apolipoprotein corona enables nanoparticle brain targeting 392
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 390
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 388
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 386
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 384
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 381
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 373
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 361
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 359
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 353
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 349
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 348
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 338
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 337
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 336
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 331
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 324
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 320
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 316
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 313
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 312
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 307
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 307
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 306
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 306
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 304
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 304
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 301
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 301
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 300
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 298
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 297
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 296
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 294
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 294
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 293
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 292
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 290
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 287
OCT2 transporter involvement in development of cisplatin toxicity 287
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 284
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 280
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 279
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 278
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 277
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 275
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 274
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 274
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 273
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 272
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 271
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 270
Multimodal experimental approach to the study of human neurological diseases 268
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 265
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 265
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 264
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 261
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 261
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 259
MSCs effect on Dark Agouti rats affected by chronic EAE 258
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 258
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 256
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 255
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 253
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 253
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 252
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 252
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 252
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 250
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 250
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 249
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 248
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 248
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 248
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 247
Genetic factors influencing the development of vincristine-induced neurotoxicity 247
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 246
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 245
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 245
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 245
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 244
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 244
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 242
Totale 31.980
Categoria #
all - tutte 145.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021366 0 0 0 0 0 0 0 0 0 0 0 366
2021/20221.946 152 234 171 177 139 181 95 106 82 143 134 332
2022/20233.423 389 830 372 325 249 529 63 179 272 51 103 61
2023/20242.946 95 97 97 143 386 712 501 163 156 68 68 460
2024/20257.844 447 891 711 363 617 292 508 280 891 1.028 662 1.154
2025/202621.347 2.949 1.858 2.441 1.768 1.942 1.266 2.841 1.061 1.702 1.743 1.310 466
Totale 49.010